Born in Lower Saxony, Dr. Nicolaus studied medicine in Regensburg and received his MD license to practice medicine in 1988 and then in 1989 he received his doctorate from the Technical University of Munich Rechts der Isar hospital. Opening a general medicine practice in one of Germany’s endemic Lyme hotspots, he started treating Lyme patients early on in his career. Given the rise and spread of tick-borne illnesses, he founded the Borreliose Centrum Augsburg (BCA) in 2006, which specializes in treating tick-borne diseases. In response to the difficult nature of diagnosing tick-borne diseases, he founded the BCA laboratory that provides a comprehensive tick-borne disease testing and advanced, innovative laboratory techniques to improve diagnostics and treatment. Being involved as a board member of ILADS from 2012 to 2017, he realized that tick-borne diseases are a growing problem in the US and advanced diagnostic tools were not accessible in the US. This led to the decision to start Infectolab Americas with Bernhard Ammann and make the improved lab testing available in the US.
Bernhard Ammann is an entrepreneur who started out as an engineer. He developed quality control processes for Siemens in the 1980s and later started his own company to provide quality control processes in the field of electronic industrial productions. He teamed up with Dr. Nicolaus, as he could see the need for providing improved quality for lab testing. Together, they are a successful team that works on multiple angles to provide access for patients to better care, diagnostics and treatment.
Felix Scholz PhD
Felix Scholz completed his doctorate in Cell Biology and carried out extensive research on skin immunology at such institutions as the Mayo Clinic and the Center for Immunology at the University of Minnesota. After leaving academia, he specialized in developing immunological diagnostic tests for infectious diseases, including tick-borne diseases. Since the summer of 2018, he has been part of the core team located at Oakdale, MN that has brought improved tick-borne disease testing to the U.S. via Infectolab Americas.